| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | oligosaccharide binding | 1.85e-06 | 20 | 91 | 4 | GO:0070492 | |
| GeneOntologyMolecularFunction | disaccharide binding | 3.16e-06 | 7 | 91 | 3 | GO:0048030 | |
| GeneOntologyMolecularFunction | galactoside binding | 7.54e-06 | 9 | 91 | 3 | GO:0016936 | |
| GeneOntologyMolecularFunction | molybdenum ion binding | 3.04e-04 | 6 | 91 | 2 | GO:0030151 | |
| GeneOntologyMolecularFunction | fatty acid elongase activity | 4.25e-04 | 7 | 91 | 2 | GO:0009922 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides | 5.14e-04 | 81 | 91 | 4 | GO:0016811 | |
| GeneOntologyMolecularFunction | deacetylase activity | 8.01e-04 | 40 | 91 | 3 | GO:0019213 | |
| GeneOntologyMolecularFunction | MHC protein complex binding | 8.61e-04 | 41 | 91 | 3 | GO:0023023 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell degranulation | 3.31e-07 | 4 | 91 | 3 | GO:0043322 | |
| GeneOntologyBiologicalProcess | regulation of oxidoreductase activity | 1.92e-06 | 84 | 91 | 6 | GO:0051341 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell degranulation | 4.58e-06 | 8 | 91 | 3 | GO:0043321 | |
| GeneOntologyBiologicalProcess | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules | 8.59e-06 | 63 | 91 | 5 | GO:0007157 | |
| GeneOntologyBiologicalProcess | negative regulation of CD4-positive, alpha-beta T cell proliferation | 3.64e-05 | 15 | 91 | 3 | GO:2000562 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell activation | 3.64e-05 | 15 | 91 | 3 | GO:0032815 | |
| GeneOntologyBiologicalProcess | negative regulation of secretion by cell | 4.54e-05 | 214 | 91 | 7 | GO:1903531 | |
| GeneOntologyBiologicalProcess | positive regulation of oxidoreductase activity | 5.02e-05 | 46 | 91 | 4 | GO:0051353 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte degranulation | 5.40e-05 | 17 | 91 | 3 | GO:0043301 | |
| GeneOntologyBiologicalProcess | natural killer cell degranulation | 6.46e-05 | 18 | 91 | 3 | GO:0043320 | |
| GeneOntologyBiologicalProcess | negative regulation of alpha-beta T cell proliferation | 7.65e-05 | 19 | 91 | 3 | GO:0046642 | |
| GeneOntologyBiologicalProcess | positive regulation of defense response to bacterium | 7.65e-05 | 19 | 91 | 3 | GO:1900426 | |
| GeneOntologyBiologicalProcess | regulation of T cell chemotaxis | 8.97e-05 | 20 | 91 | 3 | GO:0010819 | |
| GeneOntologyBiologicalProcess | negative regulation of secretion | 9.10e-05 | 239 | 91 | 7 | GO:0051048 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell differentiation | 1.04e-04 | 21 | 91 | 3 | GO:0032823 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte degranulation | 1.73e-04 | 63 | 91 | 4 | GO:0043300 | |
| GeneOntologyBiologicalProcess | regulation of defense response to bacterium | 2.01e-04 | 26 | 91 | 3 | GO:1900424 | |
| GeneOntologyBiologicalProcess | positive regulation of interleukin-6 production | 2.07e-04 | 122 | 91 | 5 | GO:0032755 | |
| GeneOntologyBiologicalProcess | regulation of CD4-positive, alpha-beta T cell proliferation | 2.51e-04 | 28 | 91 | 3 | GO:2000561 | |
| GeneOntologyBiologicalProcess | positive regulation of tumor necrosis factor production | 3.08e-04 | 133 | 91 | 5 | GO:0032760 | |
| GeneOntologyBiologicalProcess | CD4-positive, alpha-beta T cell proliferation | 3.09e-04 | 30 | 91 | 3 | GO:0035739 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte chemotaxis | 3.41e-04 | 31 | 91 | 3 | GO:1901623 | |
| GeneOntologyBiologicalProcess | positive regulation of regulatory T cell differentiation | 3.41e-04 | 31 | 91 | 3 | GO:0045591 | |
| GeneOntologyBiologicalProcess | positive regulation of tumor necrosis factor superfamily cytokine production | 3.54e-04 | 137 | 91 | 5 | GO:1903557 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte migration | 3.75e-04 | 77 | 91 | 4 | GO:2000401 | |
| GeneOntologyBiologicalProcess | negative regulation of regulated secretory pathway | 3.76e-04 | 32 | 91 | 3 | GO:1903306 | |
| GeneOntologyBiologicalProcess | fatty acid elongation, polyunsaturated fatty acid | 3.99e-04 | 7 | 91 | 2 | GO:0034626 | |
| GeneOntologyBiologicalProcess | fatty acid elongation, monounsaturated fatty acid | 3.99e-04 | 7 | 91 | 2 | GO:0034625 | |
| GeneOntologyBiologicalProcess | fatty acid elongation, unsaturated fatty acid | 3.99e-04 | 7 | 91 | 2 | GO:0019368 | |
| GeneOntologyBiologicalProcess | regulation of secretion by cell | LGALS9C FGF23 KDM5B SPHK2 LGALS9B GRIN2B CADPS2 PTGER3 GABBR1 LGALS9 CRY1 | 4.09e-04 | 740 | 91 | 11 | GO:1903530 |
| GeneOntologyBiologicalProcess | T cell chemotaxis | 4.12e-04 | 33 | 91 | 3 | GO:0010818 | |
| GeneOntologyBiologicalProcess | regulation of macrophage activation | 4.55e-04 | 81 | 91 | 4 | GO:0043030 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | 4.72e-04 | 313 | 91 | 7 | GO:0098742 | |
| GeneOntologyBiologicalProcess | receptor clustering | 4.99e-04 | 83 | 91 | 4 | GO:0043113 | |
| GeneOntologyBiologicalProcess | fatty acid elongation, saturated fatty acid | 5.30e-04 | 8 | 91 | 2 | GO:0019367 | |
| GeneOntologyBiologicalProcess | negative regulation of response to biotic stimulus | 5.52e-04 | 151 | 91 | 5 | GO:0002832 | |
| GeneOntologyBiologicalProcess | regulation of T cell differentiation in thymus | 5.79e-04 | 37 | 91 | 3 | GO:0033081 | |
| GeneOntologyBiologicalProcess | positive regulation of interleukin-1 production | 6.23e-04 | 88 | 91 | 4 | GO:0032732 | |
| GeneOntologyBiologicalProcess | natural killer cell differentiation | 6.27e-04 | 38 | 91 | 3 | GO:0001779 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity | 7.29e-04 | 40 | 91 | 3 | GO:0045953 | |
| GeneOntologyBiologicalProcess | negative regulation of CD4-positive, alpha-beta T cell activation | 7.29e-04 | 40 | 91 | 3 | GO:2000515 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immunity | 7.84e-04 | 41 | 91 | 3 | GO:0002716 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell migration | 7.84e-04 | 41 | 91 | 3 | GO:2000406 | |
| GeneOntologyBiologicalProcess | regulation of secretion | LGALS9C FGF23 KDM5B SPHK2 LGALS9B GRIN2B CADPS2 PTGER3 GABBR1 LGALS9 CRY1 | 7.90e-04 | 801 | 91 | 11 | GO:0051046 |
| GeneOntologyBiologicalProcess | positive regulation of cell activation | 8.31e-04 | 449 | 91 | 8 | GO:0050867 | |
| GeneOntologyBiologicalProcess | natural killer cell activation involved in immune response | 8.42e-04 | 42 | 91 | 3 | GO:0002323 | |
| GeneOntologyBiologicalProcess | positive regulation of macrophage activation | 8.42e-04 | 42 | 91 | 3 | GO:0043032 | |
| GeneOntologyBiologicalProcess | alpha-linolenic acid metabolic process | 8.47e-04 | 10 | 91 | 2 | GO:0036109 | |
| GeneOntologyBiologicalProcess | positive regulation of SMAD protein signal transduction | 9.02e-04 | 43 | 91 | 3 | GO:0060391 | |
| GeneOntologyBiologicalProcess | negative regulation of exocytosis | 1.03e-03 | 45 | 91 | 3 | GO:0045920 | |
| MousePheno | increased circulating xanthine level | 2.92e-05 | 2 | 76 | 2 | MP:0031490 | |
| MousePheno | abnormal circulating xanthine level | 2.92e-05 | 2 | 76 | 2 | MP:0031488 | |
| MousePheno | increased susceptibility to induced arthritis | 4.16e-05 | 36 | 76 | 4 | MP:0003724 | |
| MousePheno | increased circulating hypoxanthine level | 8.72e-05 | 3 | 76 | 2 | MP:0031487 | |
| MousePheno | abnormal circulating hypoxanthine level | 8.72e-05 | 3 | 76 | 2 | MP:0031485 | |
| MousePheno | increased urine hypoxanthine level | 8.72e-05 | 3 | 76 | 2 | MP:0031484 | |
| MousePheno | abnormal urine hypoxanthine level | 8.72e-05 | 3 | 76 | 2 | MP:0031482 | |
| MousePheno | enhanced humoral immune response | 9.94e-05 | 17 | 76 | 3 | MP:0020155 | |
| MousePheno | increased T-helper 1 cell number | 1.41e-04 | 19 | 76 | 3 | MP:0008086 | |
| MousePheno | abnormal urine xanthine level | 1.74e-04 | 4 | 76 | 2 | MP:0031480 | |
| MousePheno | increased urine xanthine level | 1.74e-04 | 4 | 76 | 2 | MP:0031479 | |
| MousePheno | increased spleen germinal center size | 2.53e-04 | 23 | 76 | 3 | MP:0008483 | |
| MousePheno | abnormal lymph node germinal center morphology | 2.53e-04 | 23 | 76 | 3 | MP:0008522 | |
| MousePheno | abnormal T-helper 1 cell number | 2.88e-04 | 24 | 76 | 3 | MP:0008085 | |
| MousePheno | abnormal lymph node secondary follicle morphology | 3.26e-04 | 25 | 76 | 3 | MP:0002346 | |
| Domain | - | 4.34e-07 | 95 | 92 | 7 | 2.60.120.200 | |
| Domain | ConA-like_dom | 1.26e-05 | 219 | 92 | 8 | IPR013320 | |
| Domain | Galectin_CRD | 5.04e-05 | 15 | 92 | 3 | IPR001079 | |
| Domain | Gal-bind_lectin | 5.04e-05 | 15 | 92 | 3 | PF00337 | |
| Domain | Gal-bind_lectin | 5.04e-05 | 15 | 92 | 3 | SM00908 | |
| Domain | GALECTIN | 5.04e-05 | 15 | 92 | 3 | PS51304 | |
| Domain | GLECT | 5.04e-05 | 15 | 92 | 3 | SM00276 | |
| Domain | Sushi | 1.25e-04 | 52 | 92 | 4 | PF00084 | |
| Domain | LamGL | 1.43e-04 | 4 | 92 | 2 | SM00560 | |
| Domain | LamG-like | 1.43e-04 | 4 | 92 | 2 | IPR006558 | |
| Domain | CCP | 1.44e-04 | 54 | 92 | 4 | SM00032 | |
| Domain | SUSHI | 1.66e-04 | 56 | 92 | 4 | PS50923 | |
| Domain | Sushi_SCR_CCP_dom | 1.78e-04 | 57 | 92 | 4 | IPR000436 | |
| Domain | ELO | 4.96e-04 | 7 | 92 | 2 | PS01188 | |
| Domain | ELO | 4.96e-04 | 7 | 92 | 2 | PF01151 | |
| Domain | ELO_fam | 4.96e-04 | 7 | 92 | 2 | IPR002076 | |
| Domain | MHC_II_b_N | 6.59e-04 | 8 | 92 | 2 | PD000328 | |
| Domain | MHC_II_b_N | 8.45e-04 | 9 | 92 | 2 | IPR000353 | |
| Domain | MHC_II_beta | 8.45e-04 | 9 | 92 | 2 | SM00921 | |
| Domain | MHC_II_beta | 8.45e-04 | 9 | 92 | 2 | PF00969 | |
| Domain | LAM_G_DOMAIN | 8.61e-04 | 38 | 92 | 3 | PS50025 | |
| Domain | Laminin_G_2 | 1.00e-03 | 40 | 92 | 3 | PF02210 | |
| Domain | TPR_7 | 1.05e-03 | 10 | 92 | 2 | PF13176 | |
| Domain | LamG | 1.32e-03 | 44 | 92 | 3 | SM00282 | |
| Domain | - | 1.70e-03 | 48 | 92 | 3 | 2.120.10.80 | |
| Domain | Kelch_2 | 1.81e-03 | 13 | 92 | 2 | IPR011498 | |
| Domain | Kelch_2 | 1.81e-03 | 13 | 92 | 2 | PF07646 | |
| Domain | MHC_II_a/b_N | 2.10e-03 | 14 | 92 | 2 | IPR014745 | |
| Domain | - | 2.10e-03 | 14 | 92 | 2 | 3.10.320.10 | |
| Domain | Kelch-typ_b-propeller | 2.52e-03 | 55 | 92 | 3 | IPR015915 | |
| Domain | Laminin_N | 2.75e-03 | 16 | 92 | 2 | IPR008211 | |
| Domain | LamNT | 2.75e-03 | 16 | 92 | 2 | SM00136 | |
| Domain | LAMININ_NTER | 2.75e-03 | 16 | 92 | 2 | PS51117 | |
| Domain | Laminin_N | 2.75e-03 | 16 | 92 | 2 | PF00055 | |
| Domain | Laminin_G | 2.93e-03 | 58 | 92 | 3 | IPR001791 | |
| Domain | - | 4.74e-03 | 21 | 92 | 2 | 2.60.60.20 | |
| Domain | PLAT | 4.74e-03 | 21 | 92 | 2 | PF01477 | |
| Domain | PLAT/LH2_dom | 4.74e-03 | 21 | 92 | 2 | IPR001024 | |
| Domain | PLAT | 4.74e-03 | 21 | 92 | 2 | PS50095 | |
| Pubmed | Galectin-9 Is Critical for Mucosal Adaptive Immunity through the T Helper 17-IgA Axis. | 1.79e-08 | 3 | 92 | 3 | 29458010 | |
| Pubmed | 1.79e-08 | 3 | 92 | 3 | 19776007 | ||
| Pubmed | 1.79e-08 | 3 | 92 | 3 | 26582205 | ||
| Pubmed | 1.79e-08 | 3 | 92 | 3 | 9153289 | ||
| Pubmed | 1.79e-08 | 3 | 92 | 3 | 33316546 | ||
| Pubmed | 1.79e-08 | 3 | 92 | 3 | 18974023 | ||
| Pubmed | 1.79e-08 | 3 | 92 | 3 | 9038233 | ||
| Pubmed | 1.79e-08 | 3 | 92 | 3 | 23144904 | ||
| Pubmed | Impaired Gal-9 Dysregulates the PBMC-Induced Th1/Th2 Imbalance in Abortion-Prone Matings. | 1.79e-08 | 3 | 92 | 3 | 29651447 | |
| Pubmed | 1.79e-08 | 3 | 92 | 3 | 28704475 | ||
| Pubmed | 1.79e-08 | 3 | 92 | 3 | 21146220 | ||
| Pubmed | 1.79e-08 | 3 | 92 | 3 | 23836896 | ||
| Pubmed | Sequence and mapping of galectin-5, a beta-galactoside-binding lectin, found in rat erythrocytes. | 1.79e-08 | 3 | 92 | 3 | 7890611 | |
| Pubmed | Galectin-9 suppresses Th17 cell development in an IL-2-dependent but Tim-3-independent manner. | 1.79e-08 | 3 | 92 | 3 | 22341088 | |
| Pubmed | Regulation of M1‑type and M2‑type macrophage polarization in RAW264.7 cells by Galectin‑9. | 1.79e-08 | 3 | 92 | 3 | 28990062 | |
| Pubmed | 1.79e-08 | 3 | 92 | 3 | 32380082 | ||
| Pubmed | 1.79e-08 | 3 | 92 | 3 | 23667648 | ||
| Pubmed | 1.79e-08 | 3 | 92 | 3 | 18579572 | ||
| Pubmed | 1.79e-08 | 3 | 92 | 3 | 28877989 | ||
| Pubmed | 1.79e-08 | 3 | 92 | 3 | 19800850 | ||
| Pubmed | 1.79e-08 | 3 | 92 | 3 | 38987795 | ||
| Pubmed | 1.79e-08 | 3 | 92 | 3 | 16990264 | ||
| Pubmed | 1.79e-08 | 3 | 92 | 3 | 18005988 | ||
| Pubmed | 1.79e-08 | 3 | 92 | 3 | 23585851 | ||
| Pubmed | 1.79e-08 | 3 | 92 | 3 | 24477688 | ||
| Pubmed | A unique role for galectin-9 in angiogenesis and inflammatory arthritis. | 1.79e-08 | 3 | 92 | 3 | 29433546 | |
| Pubmed | 1.79e-08 | 3 | 92 | 3 | 37105392 | ||
| Pubmed | 1.79e-08 | 3 | 92 | 3 | 36479526 | ||
| Pubmed | 1.79e-08 | 3 | 92 | 3 | 23242525 | ||
| Pubmed | Galectin-9 in allergic airway inflammation and hyper-responsiveness in mice. | 1.79e-08 | 3 | 92 | 3 | 19851072 | |
| Pubmed | The Role of Galectin-9 as Mediator of Atopic Dermatitis: Effect on Keratinocytes. | 1.79e-08 | 3 | 92 | 3 | 33923930 | |
| Pubmed | Alarmin function of galectin-9 in murine respiratory tularemia. | 1.79e-08 | 3 | 92 | 3 | 25898318 | |
| Pubmed | 1.79e-08 | 3 | 92 | 3 | 31937306 | ||
| Pubmed | 1.79e-08 | 3 | 92 | 3 | 21426359 | ||
| Pubmed | Intracellular Galectin-9 Enhances Proximal TCR Signaling and Potentiates Autoimmune Diseases. | 1.79e-08 | 3 | 92 | 3 | 31969388 | |
| Pubmed | 1.79e-08 | 3 | 92 | 3 | 18282810 | ||
| Pubmed | Obesity-induced galectin-9 is a therapeutic target in B-cell acute lymphoblastic leukemia. | 1.79e-08 | 3 | 92 | 3 | 35241678 | |
| Pubmed | 1.79e-08 | 3 | 92 | 3 | 24083426 | ||
| Pubmed | 1.79e-08 | 3 | 92 | 3 | 37279535 | ||
| Pubmed | The protective function of galectin-9 in liver ischemia and reperfusion injury in mice. | 1.79e-08 | 3 | 92 | 3 | 25931247 | |
| Pubmed | 1.79e-08 | 3 | 92 | 3 | 22627368 | ||
| Pubmed | 1.79e-08 | 3 | 92 | 3 | 33153471 | ||
| Pubmed | 1.79e-08 | 3 | 92 | 3 | 22052881 | ||
| Pubmed | 1.79e-08 | 3 | 92 | 3 | 17560833 | ||
| Pubmed | 1.79e-08 | 3 | 92 | 3 | 35643073 | ||
| Pubmed | Galectin-9 functionally impairs natural killer cells in humans and mice. | 1.79e-08 | 3 | 92 | 3 | 23408620 | |
| Pubmed | 7.15e-08 | 4 | 92 | 3 | 38686388 | ||
| Pubmed | 7.15e-08 | 4 | 92 | 3 | 22677125 | ||
| Pubmed | 7.15e-08 | 4 | 92 | 3 | 19234217 | ||
| Pubmed | 7.15e-08 | 4 | 92 | 3 | 35715604 | ||
| Pubmed | 7.15e-08 | 4 | 92 | 3 | 19017954 | ||
| Pubmed | Galectin-9 Targets NLRP3 for Autophagic Degradation to Limit Inflammation. | 7.15e-08 | 4 | 92 | 3 | 33963043 | |
| Pubmed | Galectin-9: A novel promoter of atherosclerosis progression. | 7.15e-08 | 4 | 92 | 3 | 36459823 | |
| Pubmed | 7.15e-08 | 4 | 92 | 3 | 33107565 | ||
| Pubmed | Galectin-9 inhibits TLR7-mediated autoimmunity in murine lupus models. | 7.15e-08 | 4 | 92 | 3 | 29611821 | |
| Pubmed | 7.15e-08 | 4 | 92 | 3 | 30763585 | ||
| Pubmed | Lgals9 deficiency ameliorates obesity by modulating redox state of PRDX2. | 7.15e-08 | 4 | 92 | 3 | 33727589 | |
| Pubmed | Tim-3-Galectin-9 pathway involves the suppression induced by CD4+CD25+ regulatory T cells. | 7.15e-08 | 4 | 92 | 3 | 19362679 | |
| Pubmed | 7.15e-08 | 4 | 92 | 3 | 25578313 | ||
| Pubmed | 7.15e-08 | 4 | 92 | 3 | 29844236 | ||
| Pubmed | Galectin-9/TIM-3 interaction regulates virus-specific primary and memory CD8 T cell response. | 7.15e-08 | 4 | 92 | 3 | 20463811 | |
| Pubmed | 7.15e-08 | 4 | 92 | 3 | 32855403 | ||
| Pubmed | Galectin-3 mediates oligomerization of secreted hensin using its carbohydrate-recognition domain. | 7.15e-08 | 4 | 92 | 3 | 23657851 | |
| Pubmed | 7.15e-08 | 4 | 92 | 3 | 18826117 | ||
| Pubmed | 7.15e-08 | 4 | 92 | 3 | 24333756 | ||
| Pubmed | 7.15e-08 | 4 | 92 | 3 | 38853593 | ||
| Pubmed | Galectin-9 controls the therapeutic activity of 4-1BB-targeting antibodies. | 7.15e-08 | 4 | 92 | 3 | 24958847 | |
| Pubmed | 7.15e-08 | 4 | 92 | 3 | 30120235 | ||
| Pubmed | [Expression of Galectin-9 and Tim-3 in lungs of mice with asthma]. | 7.15e-08 | 4 | 92 | 3 | 21575348 | |
| Pubmed | Activation of Tim-3-Galectin-9 pathway improves survival of fully allogeneic skin grafts. | 7.15e-08 | 4 | 92 | 3 | 18346632 | |
| Pubmed | 7.15e-08 | 4 | 92 | 3 | 11839756 | ||
| Pubmed | 7.15e-08 | 4 | 92 | 3 | 19670381 | ||
| Pubmed | 7.15e-08 | 4 | 92 | 3 | 25450716 | ||
| Pubmed | The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. | 7.15e-08 | 4 | 92 | 3 | 16286920 | |
| Pubmed | Galectin-9 regulates the threshold of B cell activation and autoimmunity. | 7.15e-08 | 4 | 92 | 3 | 34369876 | |
| Pubmed | 7.15e-08 | 4 | 92 | 3 | 33203936 | ||
| Pubmed | Influence of galectin-9/Tim-3 interaction on herpes simplex virus-1 latency. | 7.15e-08 | 4 | 92 | 3 | 22021615 | |
| Pubmed | 1.78e-07 | 5 | 92 | 3 | 29242193 | ||
| Pubmed | 1.78e-07 | 5 | 92 | 3 | 28951537 | ||
| Pubmed | Galectin-9 mediates neutrophil capture and adhesion in a CD44 and β2 integrin-dependent manner. | 1.78e-07 | 5 | 92 | 3 | 34847625 | |
| Pubmed | 1.78e-07 | 5 | 92 | 3 | 22469568 | ||
| Pubmed | 1.78e-07 | 5 | 92 | 3 | 25158758 | ||
| Pubmed | C/EBPzeta (CHOP/Gadd153) is a negative regulator of LPS-induced IL-6 expression in B cells. | 1.78e-07 | 5 | 92 | 3 | 19782405 | |
| Pubmed | Embryonic implantation in galectin 1/galectin 3 double mutant mice. | 1.78e-07 | 5 | 92 | 3 | 9566950 | |
| Pubmed | 1.78e-07 | 5 | 92 | 3 | 26278059 | ||
| Pubmed | 1.78e-07 | 5 | 92 | 3 | 37352334 | ||
| Pubmed | 1.78e-07 | 5 | 92 | 3 | 33664349 | ||
| Pubmed | The glucose transporter 2 regulates CD8+ T cell function via environment sensing. | 1.78e-07 | 5 | 92 | 3 | 37884694 | |
| Pubmed | 1.78e-07 | 5 | 92 | 3 | 21385853 | ||
| Pubmed | 3.56e-07 | 6 | 92 | 3 | 28394331 | ||
| Pubmed | Tim3 binding to galectin-9 stimulates antimicrobial immunity. | 3.56e-07 | 6 | 92 | 3 | 20937702 | |
| Pubmed | 3.56e-07 | 6 | 92 | 3 | 8674632 | ||
| Pubmed | 3.56e-07 | 6 | 92 | 3 | 23296703 | ||
| Pubmed | Role of galectin-1 in the developing mouse olfactory system. | 6.22e-07 | 7 | 92 | 3 | 8873770 | |
| Pubmed | 9.94e-07 | 8 | 92 | 3 | 23751344 | ||
| Pubmed | 9.94e-07 | 8 | 92 | 3 | 31661141 | ||
| Pubmed | 9.94e-07 | 8 | 92 | 3 | 36883358 | ||
| Pubmed | 1.49e-06 | 9 | 92 | 3 | 21670307 | ||
| Pubmed | Galectin-9-CD44 interaction enhances stability and function of adaptive regulatory T cells. | 1.49e-06 | 9 | 92 | 3 | 25065622 | |
| Pubmed | 3.87e-06 | 12 | 92 | 3 | 23817958 | ||
| GeneFamily | Galectins | 2.34e-05 | 15 | 69 | 3 | 629 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 6.59e-05 | 57 | 69 | 4 | 1179 | |
| Coexpression | MIKKELSEN_MCV6_LCP_WITH_H3K4ME3 | 2.74e-06 | 174 | 92 | 7 | MM836 | |
| Coexpression | MIKKELSEN_MEF_LCP_WITH_H3K4ME3 | 1.11e-05 | 142 | 92 | 6 | MM840 | |
| Coexpression | NABA_MATRISOME | LGALS9C FGF23 MFAP4 IGFBP6 LGALS9B ZPLD1 ANGPTL4 MUC19 LAMB3 PAPPA USH2A CTSO VWA5B1 LGALS9 | 1.33e-05 | 1026 | 92 | 14 | M5889 |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.82e-07 | 147 | 91 | 6 | b66ccc710b3c04f6fc7fed69f3c892fc110e98fc | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-06 | 179 | 91 | 6 | a3922476f33d2e4137a12dbda21a1703dff79684 | |
| ToppCell | COVID-19-kidney|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.37e-06 | 187 | 91 | 6 | d23aae9419d460b78b1d4092d7acd9108a47cfbe | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.59e-06 | 190 | 91 | 6 | b3bccf4dd95e986db3cee324a6737f5fcc22e8e5 | |
| ToppCell | COVID-19-kidney-CNT|kidney / Disease (COVID-19 only), tissue and cell type | 2.75e-06 | 192 | 91 | 6 | d32ae226d95b4b6adb99d14b602be09b661d4cd9 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.92e-06 | 194 | 91 | 6 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.19e-06 | 197 | 91 | 6 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Serous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.48e-06 | 200 | 91 | 6 | 7c2d499af60654b7b28f172ac2c914ad49fb74b4 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-1|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 3.48e-06 | 200 | 91 | 6 | 16a3685c41194a0a4a772e4eee372160263480e0 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-05 | 145 | 91 | 5 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-05 | 160 | 91 | 5 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-05 | 160 | 91 | 5 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.06e-05 | 162 | 91 | 5 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.25e-05 | 165 | 91 | 5 | 9bd332e5ede759a00a47728ea5558c215efdd77a | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-05 | 169 | 91 | 5 | 87116c33c5ca8cb1862e103e5607b1df4d264569 | |
| ToppCell | COVID-19-kidney-PEC|kidney / Disease (COVID-19 only), tissue and cell type | 2.75e-05 | 172 | 91 | 5 | 36a96714a0eb6ac438648135336c9791881ddadb | |
| ToppCell | facs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.98e-05 | 175 | 91 | 5 | 887e75fc90e59a6394d62f3c048a9cfdf6707725 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.24e-05 | 178 | 91 | 5 | a74e5a390cbeaca9de1fdb7b2a0e50783bd202dd | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.24e-05 | 178 | 91 | 5 | 1bddbc083c36657bd6910f7466126ab325e88176 | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.24e-05 | 178 | 91 | 5 | 544379f5a6145429762258d426b876bb36c112f5 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.32e-05 | 179 | 91 | 5 | d3438fed0d85d5ed5afa8ff820c45143d77b6c0d | |
| ToppCell | AT1-AT2_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 3.41e-05 | 180 | 91 | 5 | 3c7b2033821f9e34e2924bd8655f566edcbcc7d3 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.41e-05 | 180 | 91 | 5 | 023ec0b080c8a5cd0f36e83c6b17d4be3c01edb5 | |
| ToppCell | COVID-19-kidney-CD-IC-B|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.60e-05 | 182 | 91 | 5 | ee6a8c356bbbdae55e4ea858337e079491f9f4aa | |
| ToppCell | COVID-19-kidney-Distal_Epi_Doublet_(PCT)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.60e-05 | 182 | 91 | 5 | 9d67717a6e13bcb54c1297a3e4e3abf4e51628a3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.69e-05 | 183 | 91 | 5 | 2e831a4d99c6f983793df71c0994124c943c6da9 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.79e-05 | 184 | 91 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | wk_08-11-Hematologic-Myeloid-Non-cla._mono.|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.79e-05 | 184 | 91 | 5 | 324f91b70913bda3509e234aaf23b46fad91e076 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.79e-05 | 184 | 91 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.79e-05 | 184 | 91 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_RPL31P31|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.89e-05 | 185 | 91 | 5 | a1b2525da018abe458908cab7268bd403ee98d92 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.99e-05 | 186 | 91 | 5 | 08632045d499e61dd96ff29a5a9a208afe58dc58 | |
| ToppCell | wk_08-11-Hematologic-Myeloid-S100A12-lo_cla._mono.|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.99e-05 | 186 | 91 | 5 | be50f5c7f32b3126442ebff1e7d38aa78b6e4e71 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.99e-05 | 186 | 91 | 5 | b87acc80b7baa41681e4ed11d5537b9fbf5832f5 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.09e-05 | 187 | 91 | 5 | 2d17408b3b5f09d135084fd7ccce98e6b5ca632b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.09e-05 | 187 | 91 | 5 | e3095455d2f255854f339f6b05fa87852af0700f | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic-Myeloid-Monocytes|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.20e-05 | 188 | 91 | 5 | 085b61dfad373e5c39f2496539fbfed1b588115a | |
| ToppCell | COVID-19-kidney-CD-PC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.20e-05 | 188 | 91 | 5 | 8f9996c3f3b27efaaae8960a66af77412de9c7ef | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.31e-05 | 189 | 91 | 5 | 3a295c215b5c18e7c673f92b7af5be523421682c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.31e-05 | 189 | 91 | 5 | 8ff3c3232eff9de4b5c9b22ecb82bc509d773f58 | |
| ToppCell | 368C-Myeloid-Macrophage|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.31e-05 | 189 | 91 | 5 | e62355be0d136e2b7c739848022292e9c6af7392 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.31e-05 | 189 | 91 | 5 | a9864873b19ab3e60acf11f288fa7275badc2e42 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.31e-05 | 189 | 91 | 5 | c9565e962a13a7713056ec3dbb1b67d24f9889c7 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibro-meso-mesothelial_cell-Mesothelium-Mesothelium_L.2.6.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.41e-05 | 190 | 91 | 5 | f39ce1678fc375eb2a3af781ddb772b0f12c5744 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.41e-05 | 190 | 91 | 5 | 4836ea19308d2a96694f12ab0653b7ce7b101d2f | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.41e-05 | 190 | 91 | 5 | 591310e615700321a010a4b90405cbbbbdb3aade | |
| ToppCell | 390C-Myeloid-Macrophage|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.41e-05 | 190 | 91 | 5 | f933d971f092c4e56e9f670a9205b688c8b1ca28 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.53e-05 | 191 | 91 | 5 | f5ce33af56178333730be308253943c54a0724cf | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.53e-05 | 191 | 91 | 5 | 96b78b4e819ea6052334bfcbc7abbf35897df885 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.64e-05 | 192 | 91 | 5 | a8b7c539dc3037071bf068f372e4215563e11de4 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.64e-05 | 192 | 91 | 5 | 2143e1fad2e88b90d668e12af37b2092d379090f | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.64e-05 | 192 | 91 | 5 | 904c003c4f73b1dfc8243cee02aad2676c515e50 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-Monocytes|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.76e-05 | 193 | 91 | 5 | c0509798ce06da0ec725c0c7b5cc195455f2c29f | |
| ToppCell | PND01|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.76e-05 | 193 | 91 | 5 | c291345c11cfcbceacbdc001a5851f67478a2779 | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 4.87e-05 | 194 | 91 | 5 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.99e-05 | 195 | 91 | 5 | ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_1_(HAND1+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.12e-05 | 196 | 91 | 5 | fd0a2b863dedaf08d18e7f67da18ac7e853991e4 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.12e-05 | 196 | 91 | 5 | 2793ad692d49b3ee78a5cd2d8e0220bf5188a686 | |
| ToppCell | RA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 5.12e-05 | 196 | 91 | 5 | e8cbda03837f1f26470a9d93aa7fdaa04e08e38a | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.24e-05 | 197 | 91 | 5 | c7b33d64e5cba3a8fc6f2d6aa85ebc83893195de | |
| ToppCell | distal-mesenchymal-Adventitial_Fibroblast-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.37e-05 | 198 | 91 | 5 | bfd720e2dae3b6b3dc2bf8b2096c554fd456e756 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.37e-05 | 198 | 91 | 5 | cc808d872d2404a79ec119bb0be62688a30c93a7 | |
| ToppCell | Fetal_29-31_weeks|World / Lineage, Cell type, age group and donor | 5.50e-05 | 199 | 91 | 5 | 5b9d355795dd03a22f0961dfd143425c367a4654 | |
| ToppCell | mLN-Dendritic_cell-cDC2|mLN / Region, Cell class and subclass | 5.50e-05 | 199 | 91 | 5 | cb17bccb47d04f7793709f9a4376fcc8ce95430c | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-immature_mesenchymal_cell|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.50e-05 | 199 | 91 | 5 | bb201deb281619113edcd1de2af2d3eb21b967b8 | |
| ToppCell | mLN-(5)_Dendritic_cell-(50)_cDC2|mLN / shred on region, Cell_type, and subtype | 5.50e-05 | 199 | 91 | 5 | 8d1b18596a0965427abefe0be744c74e4c11d5d3 | |
| ToppCell | kidney_cells-Adult_normal_reference-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.50e-05 | 199 | 91 | 5 | 0a9783808528bc4c6d797d849a9177330c8fb867 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-B3GAT2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 5.63e-05 | 200 | 91 | 5 | 858421b91f5207b7934b5c219752cb9322a3da31 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-H-|390C / Donor, Lineage, Cell class and subclass (all cells) | 5.63e-05 | 200 | 91 | 5 | ec7d6a08e34bcad5b3bbff56ebef96ae17e4cefd | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-4|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 5.63e-05 | 200 | 91 | 5 | 7642a14855589b0b3f68dbdc9e4d3fc7291854f7 | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.63e-05 | 200 | 91 | 5 | 8ab0051544ea32eb8b3f7f8ba7582deaf8bf26c0 | |
| ToppCell | mild-Non-classical_Monocyte|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.63e-05 | 200 | 91 | 5 | 692b48da9fd56bafcb3c8b33b0fe369160881c45 | |
| ToppCell | Biopsy_IPF-Epithelial-Basal|Biopsy_IPF / Sample group, Lineage and Cell type | 5.63e-05 | 200 | 91 | 5 | 5cea84581201cee7ba8141b96e65864f4fd67113 | |
| ToppCell | mild-Non-classical_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.63e-05 | 200 | 91 | 5 | 334bab6bf93d455f3526e817ea5785d8b6ee531c | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-B3GAT2-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 5.63e-05 | 200 | 91 | 5 | a7022762c1d8aedb7b3e9605873b1e68b9907b35 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-4-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.63e-05 | 200 | 91 | 5 | 444c72334df421375ae6fc69b0adfd4950d49a43 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-4|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.63e-05 | 200 | 91 | 5 | 5826c17da67bdaba3a828792279004218d8260c8 | |
| ToppCell | Biopsy_Other_PF-Epithelial-Basal|Biopsy_Other_PF / Sample group, Lineage and Cell type | 5.63e-05 | 200 | 91 | 5 | 7098ae4b0ea8ba607519eaed8577c577530fc2a1 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-H|390C / Donor, Lineage, Cell class and subclass (all cells) | 5.63e-05 | 200 | 91 | 5 | 671e731977c58a0c44c36b56422085d93d999aad | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.63e-05 | 200 | 91 | 5 | fb53be20392a8309a7393774c774a1b1aec6e676 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-B3GAT2--L4-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 5.63e-05 | 200 | 91 | 5 | 2131c8e7fa054b79906eaf60536da892438b09cd | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Bcl6-Excitatory_Neuron.Slc17a7.Bcl6-Pvalb_(Layer_5a)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.55e-04 | 51 | 91 | 3 | 28d6b12c44ad308560931d275e0dd0243a555bf3 | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet-Platelet-plt_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.74e-04 | 136 | 91 | 4 | 27a41463e6f16deb5b1d4f17fefded9959038c07 | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet-Platelet-plt_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.74e-04 | 136 | 91 | 4 | 88b5c839d0446c6d6b7e81fc4d48f5e7e96eea11 | |
| ToppCell | facs-Liver-Hepatocytes-3m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-04 | 139 | 91 | 4 | 82bf5ba69a907fbd9b4e2b2dd1dd27b8c4c75f25 | |
| ToppCell | facs-Liver-Hepatocytes-3m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-04 | 139 | 91 | 4 | fc9ac09c2106e88104a52575832d71d17765eec8 | |
| ToppCell | facs-Liver-Hepatocytes-3m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-04 | 139 | 91 | 4 | fc4b39ac9a10cf0acacfebbc4295edf324d930d5 | |
| ToppCell | facs-Liver-Hepatocytes-3m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-04 | 139 | 91 | 4 | 4ddfbc36a0560fb70594627178bff652ab1ea3e9 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Alveolar_Mac|Myeloid_cells / Location, Cell class and cell subclass | 2.00e-04 | 141 | 91 | 4 | 399380de5ea09e22fd128e3e55fffeffc4874c15 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Slc17a8|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.52e-04 | 60 | 91 | 3 | 40f29dfdbb17d39d8e6bb69dc5066fca3cd03308 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Slc17a8-Inhibitory_Neuron.Gad1Gad2Slc17a8_Sst.Ncam2_(Interneuron,__GABA/Glutamate_co-releasing?)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.52e-04 | 60 | 91 | 3 | 3a58f7a8e3d8a544286b7a3fe62efac8a0a0bb11 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Slc17a8-Inhibitory_Neuron.Gad1Gad2Slc17a8_Sst.Ncam2_(Interneuron,__GABA/Glutamate_co-releasing?)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.52e-04 | 60 | 91 | 3 | ce13bbda7d105e1cb421790fb50d3b55ba2ed09a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.53e-04 | 150 | 91 | 4 | 87968ce885a4959616f0321f58517fe8029ba1b1 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-04 | 152 | 91 | 4 | 82a493ffb2f1704cd6f68a82d970fe12f537d20e | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.94e-04 | 156 | 91 | 4 | 4d2679e7639758c49fc25a2deb9109b08f0a3e57 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.01e-04 | 157 | 91 | 4 | beab0ac47202266b04543c02cfcdda012375e879 | |
| ToppCell | 3'-Airway_Nasal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.31e-04 | 161 | 91 | 4 | 3a5f2877e3b29463a3a6da05009b0ab8747b4c47 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.39e-04 | 162 | 91 | 4 | 285e6d553f485fd9f1075c4e1b940da251b5ea35 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L5_RORB_SNHG7|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.39e-04 | 162 | 91 | 4 | daacccf8b1374680803f49135673a00e09691cde | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-plasma_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.47e-04 | 163 | 91 | 4 | 5efecdd8a069a822bc9d35b407092925a865e629 | |
| Disease | Hereditary xanthinuria | 8.59e-06 | 2 | 87 | 2 | cv:C5779508 | |
| Disease | Autistic Disorder | 1.25e-05 | 261 | 87 | 7 | C0004352 | |
| Disease | renal cell carcinoma | 2.62e-04 | 42 | 87 | 3 | EFO_0000681 | |
| Disease | blood nickel measurement | 4.46e-04 | 120 | 87 | 4 | EFO_0007583 | |
| Disease | urate measurement, bone density | 4.89e-04 | 619 | 87 | 8 | EFO_0003923, EFO_0004531 | |
| Disease | cholesteryl ester 24:5 measurement | 5.56e-04 | 12 | 87 | 2 | EFO_0021448 | |
| Disease | triglycerides in LDL measurement | 6.13e-04 | 56 | 87 | 3 | EFO_0022320 | |
| Disease | thalamus volume change measurement | 7.64e-04 | 14 | 87 | 2 | EFO_0021496 | |
| Disease | triglycerides in medium LDL measurement | 8.26e-04 | 62 | 87 | 3 | EFO_0022322 | |
| Disease | Allergic Reaction | 8.65e-04 | 63 | 87 | 3 | C1527304 | |
| Disease | pancreas fat measurement | 8.80e-04 | 15 | 87 | 2 | EFO_0600049 | |
| Disease | Hypersensitivity | 9.06e-04 | 64 | 87 | 3 | C0020517 | |
| Disease | body mass index, type 2 diabetes mellitus | 1.00e-03 | 16 | 87 | 2 | EFO_0004340, MONDO_0005148 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.08e-03 | 152 | 87 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | metabolite measurement, diet measurement | 1.22e-03 | 71 | 87 | 3 | EFO_0004725, EFO_0008111 | |
| Disease | testosterone measurement | ARHGEF40 TTC28 EGR2 TSHZ2 LAMB3 XDH CSMD3 USH2A TRIM38 FAF1 ARAP1 | 1.30e-03 | 1275 | 87 | 11 | EFO_0004908 |
| Disease | pentachlorophenol measurement | 1.33e-03 | 73 | 87 | 3 | EFO_0022071 | |
| Disease | parathion measurement | 1.33e-03 | 73 | 87 | 3 | EFO_0022070 | |
| Disease | potassium chromate measurement | 1.33e-03 | 73 | 87 | 3 | EFO_0022072 | |
| Disease | mercuric chloride measurement | 1.33e-03 | 73 | 87 | 3 | EFO_0022068 | |
| Disease | heptachlor epoxide measurement | 1.33e-03 | 73 | 87 | 3 | EFO_0022067 | |
| Disease | methoxychlor measurement | 1.33e-03 | 73 | 87 | 3 | EFO_0022069 | |
| Disease | 4,6-dinitro-o-cresol measurement | 1.33e-03 | 73 | 87 | 3 | EFO_0022053 | |
| Disease | 2,4,5-trichlorophenol measurement | 1.33e-03 | 73 | 87 | 3 | EFO_0022052 | |
| Disease | azinphos methyl measurement | 1.33e-03 | 73 | 87 | 3 | EFO_0022055 | |
| Disease | aldrin measurement | 1.33e-03 | 73 | 87 | 3 | EFO_0022054 | |
| Disease | dicofol measurement | 1.33e-03 | 73 | 87 | 3 | EFO_0022060 | |
| Disease | disulfoton measurement | 1.33e-03 | 73 | 87 | 3 | EFO_0022062 | |
| Disease | dieldrin measurement | 1.33e-03 | 73 | 87 | 3 | EFO_0022061 | |
| Disease | endrin measurement | 1.33e-03 | 73 | 87 | 3 | EFO_0022064 | |
| Disease | endosulfan measurement | 1.33e-03 | 73 | 87 | 3 | EFO_0022063 | |
| Disease | heptachlor measurement | 1.33e-03 | 73 | 87 | 3 | EFO_0022066 | |
| Disease | ethion measurement | 1.33e-03 | 73 | 87 | 3 | EFO_0022065 | |
| Disease | chlorpyrifos measurement | 1.33e-03 | 73 | 87 | 3 | EFO_0022057 | |
| Disease | cadmium chloride measurement | 1.33e-03 | 73 | 87 | 3 | EFO_0022056 | |
| Disease | diazinon measurement | 1.33e-03 | 73 | 87 | 3 | EFO_0022059 | |
| Disease | dibutyl phthalate measurement | 1.33e-03 | 73 | 87 | 3 | EFO_0022058 | |
| Disease | environmental exposure measurement | 1.33e-03 | 73 | 87 | 3 | EFO_0008360 | |
| Disease | Retinitis pigmentosa | 1.38e-03 | 74 | 87 | 3 | cv:C0035334 | |
| Disease | DDT metabolite measurement | 1.38e-03 | 74 | 87 | 3 | EFO_0007886 | |
| Disease | aspartate aminotransferase measurement | 1.39e-03 | 904 | 87 | 9 | EFO_0004736 | |
| Disease | level of Sphingomyelin (d38:2) in blood serum | 1.42e-03 | 19 | 87 | 2 | OBA_2045179 | |
| Disease | diacylglycerol 38:5 measurement | 1.42e-03 | 19 | 87 | 2 | EFO_0020067 | |
| Disease | alpha-tocopherol measurement | 1.58e-03 | 20 | 87 | 2 | EFO_0007898 | |
| Disease | advanced glycosylation end product-specific receptor ligand measurement | 1.74e-03 | 21 | 87 | 2 | EFO_0010762 | |
| Disease | S-6-hydroxywarfarin to S-warfarin ratio measurement | 2.27e-03 | 88 | 87 | 3 | EFO_0803332 | |
| Disease | Sjogren's syndrome (is_marker_for) | 2.27e-03 | 24 | 87 | 2 | DOID:12894 (is_marker_for) | |
| Disease | retinitis pigmentosa (implicated_via_orthology) | 2.88e-03 | 27 | 87 | 2 | DOID:10584 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GYDTPLHFACKFGNA | 411 | Q86XL3 | |
| GACFLRHGDQFSLYA | 1156 | Q8TER5 | |
| FGTCSHSNLNGQYFR | 351 | Q9BY76 | |
| GFNITYNTFGHNECP | 821 | Q7Z407 | |
| RCYFPSFLGGNRSQF | 106 | Q8TDN7 | |
| SSRNYFGAQPHYRLC | 271 | Q86XR8 | |
| CQSGFAYHLFPRSRL | 786 | Q7L2E3 | |
| TFRQFHARLCGYFGT | 141 | Q9HA90 | |
| GEKNCSYFRHFNPGE | 76 | Q06432 | |
| YPGFFPSQCQRDLHG | 226 | P11161 | |
| FGHPYRGASQFLASA | 6 | P78412 | |
| SPSHGGQYRCYSAHN | 286 | Q8N149 | |
| STFALSFGGNPLHCN | 231 | Q96NI6 | |
| GFDALSNGAHFICNY | 161 | P48060 | |
| HNLLVCSVNGFYPGS | 141 | Q30154 | |
| VPCGHSYFGATLNSF | 161 | Q9NYP7 | |
| GYHIGRNQFPFVCQA | 651 | Q9UBS5 | |
| HFNPRFEDGGYVVCN | 61 | Q6DKI2 | |
| PCATSNYTGFANKHG | 251 | Q2KJY2 | |
| HFNPRFEDGGYVVCN | 61 | Q3B8N2 | |
| HFNPRFEDGGYVVCN | 61 | O00182 | |
| GNSHRFSFCQYPFVI | 361 | Q5U5R9 | |
| CNNHAPLFNRSSYDG | 451 | Q9NYQ8 | |
| TFDGVKYNFPGNCHF | 826 | Q7Z5P9 | |
| GYGGDAPFCTRLNHS | 6 | P43115 | |
| THGGNYRCFGSFRAL | 286 | Q8N743 | |
| FGSQYCHAPLGRQHS | 86 | Q9H4S2 | |
| RAHIPNFTFNLGYSG | 346 | P52848 | |
| NGGSFQPGCHFLELY | 246 | P11150 | |
| SYNNIRDLPSFNGCH | 351 | Q9BXB1 | |
| AGCFPLFHRGEYSAS | 676 | Q9BXB1 | |
| HLFCYPAQSNFSGVR | 196 | Q96EN8 | |
| ALFGGSQPQSCRYFN | 296 | Q8IXQ5 | |
| TFPRAYHSGFNQGFN | 581 | Q9UGL1 | |
| GPGNDTCGFHSFFNT | 616 | Q13219 | |
| LQLGFSFSFPCHQTG | 161 | P52790 | |
| LCGHYNNDGNAPSFG | 161 | Q06190 | |
| LPYRGSNSIAHFFCE | 166 | Q9H210 | |
| PILNGGAAFHCARTY | 531 | Q9HBE1 | |
| RPDGNCFYRAFGFSH | 86 | Q96FW1 | |
| NRSPHQAFRSGGFIC | 326 | Q8WZ79 | |
| CGQSFFGPTLNSFIH | 166 | Q9NXB9 | |
| NIFGSHYFDPENCRF | 101 | Q9GZV9 | |
| HLGGYFFIQCRQDSP | 651 | Q6MZW2 | |
| FQQFFHCYCPVGFGR | 406 | Q16526 | |
| NPRHYGQSGFFASLC | 416 | O75061 | |
| GSGSSPAACRFAHYF | 11 | Q6ZUT9 | |
| ENQISHFRYCFPFGR | 756 | Q86UW7 | |
| HNLLVCSVNGFYPGS | 141 | P13762 | |
| EARVNCSHPFGAFRY | 456 | P16109 | |
| RHHPGTFGFNTTCYF | 656 | P16109 | |
| RFGPFHSNNEIYCNR | 201 | Q9BQ90 | |
| GFTGLTYANPQGCHR | 416 | Q13751 | |
| GFQSLDCGSSFYHPT | 111 | Q3LI76 | |
| QSPNLYCHFANGIGE | 2751 | Q9NYC9 | |
| FSSRYGDCHPVFFIG | 341 | Q9UNN5 | |
| SLHRYDNGNFFPGSG | 891 | Q9UQL6 | |
| PQGYQGSFHSIQSCF | 511 | Q8NBF1 | |
| CHCPFDNLSRTFYGG | 421 | P82279 | |
| GAQTLYVPNCDHRGF | 181 | P24592 | |
| TFPACHRNGDFTGGY | 711 | Q6ZVC0 | |
| NCTRFHPNSNYVATG | 631 | Q15542 | |
| KDHYFGFDPQTGRCQ | 986 | O75445 | |
| RFIGNGYCKFPSSTH | 1521 | O75445 | |
| GNAPCGHYTFKFPQA | 206 | Q9H2W6 | |
| YNGNTGCHIFTFPKA | 426 | O00635 | |
| NFFRYHGLSSLCNLG | 156 | Q6UW68 | |
| PFYFSFSRCTLSGGH | 316 | Q96ME1 | |
| SCHFANLNGFYLGGS | 211 | P55083 | |
| PGSQHDASCAYRQFS | 426 | P81133 | |
| ALNPQCHYGFGNLRS | 141 | Q6PI26 | |
| GHIAFASYNSPRNDC | 271 | Q96N87 | |
| CVPGYRLHSGNEQFS | 96 | Q9BY15 | |
| PFKAQNGLCHYFSGS | 196 | P43234 | |
| SGGFHDRYFILNSSC | 1296 | Q96P48 | |
| FNGYNCDANLHSRFP | 21 | Q8TCW7 | |
| YSCSAVPHQGRGFSQ | 746 | Q9NXC5 | |
| SHFSLGCPQLGYAAA | 591 | Q9NRA0 | |
| PQHTYFINCGDSRGL | 136 | P35813 | |
| ACGFGPSFFLSHQTA | 1166 | Q96HA7 | |
| YNAGNICNHFFTRGF | 326 | Q3KQV9 | |
| NSGNPFHYFSYGVAC | 1146 | P47989 | |
| PGAINSCRSEYHAAF | 611 | Q9Y2I9 | |
| KGCFSYQNSPGSHLS | 61 | Q9NRE2 | |
| VHRGGYNGFNQCLPA | 126 | P17038 | |
| AFFYHSNCKEPGIAG | 111 | Q9P016 | |
| GNFHCSRGEYVQAAP | 601 | Q96AY4 | |
| CGKAFYSPSSFQRHE | 276 | Q8N8L2 | |
| RHLQGYNPFDQGCAS | 231 | Q8WVZ1 | |
| NSPRGYFHTFAGDTC | 101 | O00401 | |
| GNCFSFGTYFNPHTV | 661 | O60294 | |
| ATNRFRFHFQGPCGT | 281 | Q9NXA8 | |
| HAFSTRCYSFGIGPN | 481 | Q5TIE3 | |
| RHNYRTCFPQYLNGG | 351 | A6NNM8 | |
| GGNFCRSCPSKLHNY | 1211 | Q13224 |